Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Org 34517 adjunctive therapy dose-finding study in psychotic major depression
2004-000050-23Phase 2Completed
- Sponsor
- Organon & Co.
- Start
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ORG-34517 in major depressive disorder (3 arms), sponsored by Organon & Co. Primary endpoint: PANSS positive symptoms score proportion of 50% responders at both Day 8 and Day 43. Started Jul 2004; status: completed.
02
Drugs
ORG-34517
03
Conditions
major depressive disorder
Beyond the preview
Go deeper on 2004-000050-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000050-23.